Cerbios successfully passes a general FDA cGMP inspection
It is with pleasure that we announce that on Friday the 27th of April 2018, Cerbios-Pharma SA (from now on CERBIOS) successfully passed a general FDA GMP inspection.
Originally, the inspection was scheduled to last five days.
Due to the excellent results, the inspector decided to close the audit in the middle of the fifth day, without issuing any 483 observation.
Bio International 2018
04/06 - 07/06
Boston Convention & Exhibition Center: 415 Summer St, Boston, MA 02210.
Stand SWISS Biotech Pavilion nr. 2221
Swiss Venture Club Prix 2015
Cerbios has been awarded second place at the bi-annual Swiss Venture Club Prix.
“This is an important recognition for Cerbios, the founders that created it in the late 70’s, the management and all employees that made this possible” confirms Gabriel Haering, Cerbios’ CEO.
“Being one of the six finalists chosen among 50 companies representing different industrial branches in Ticino was already a great achievement. Reaching the second place among the six finalist is splendid!”
The main criteria for the choice of finalists and winners were the following:
- Innovation as key company value
- Regional presence and impact at different levels
- An excellent track record
- Leadership in the reference market
- Operational sustainability
This award is not only a recognition for Cerbios’ strategy and approach but also a commitment towards the future in order to maintain the high standard achieved.